Výsledky vyhledávání - "Laura A. Lucaciu"

Akademický článek

Real-world experience with tofacitinib in ulcerative colitis: a systematic review and meta-analysis

Autor: Laura A. Lucaciu, Nathan Constantine-Cooke, Nikolas Plevris, Spyros Siakavellas, Lauranne A.A.P. Derikx, Gareth-Rhys Jones, Charles W. Lees

Publikováno v: Therapeutic Advances in Gastroenterology, Vol 14 (2021)

Background and aims: Tofacitinib is a Janus kinase inhibitor (JAKi) recently approved for the treatment of moderate to severe ulcerative colitis (UC) based on robust efficacy and safety data derived from OCTAVE clinical trials. Evidence on the outcom

Externí odkaz: https://doaj.org/article/0d603ef9e2ef4abfa25ca31213ebca59

Zobrazit plný text záznamu

Small molecule drugs in the treatment of inflammatory bowel diseases: which one, when and why? – a systematic review

Autor: Radu Seicean, Laura A. Lucaciu, Andrada Seicean

Publikováno v: European Journal of Gastroenterology & Hepatology. 32:669-677

In the 'treat-to-target' era of inflammatory bowel disease (IBD) management, small molecule drugs (SMDs) represent a promising alternative to biomolecular drugs. Moreover, increasing failure rates of anti-tumor necrosis factor α agents have contribu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83a920d4e12e0004b4a5eed40a56c0bc
https://doi.org/10.1097/meg.0000000000001730

Zobrazit plný text záznamu

Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease

Autor: Cristina Adela Iuga, Radu Seicean, Laura A. Lucaciu, Ștefan C. Vesa, Maria Ilieș, Andrada Seicean, Shahida Din

Publikováno v: Journal of Personalized Medicine
Volume 11
Issue 11
Lucaciu, L A, Ilieș, M, Vesa, Ș C, Seicean, R, Din, S, Iuga, C A & Seicean, A 2021, ' Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease ', Journal of personalized medicine, vol. 11, no. 11, pp. 1130 . https://doi.org/10.3390/jpm11111130
Journal of Personalized Medicine, Vol 11, Iss 1130, p 1130 (2021)

Interleukin (IL)-17 and IL-23 are crucial for mediating gut mucosal inflammation in inflammatory bowel disease (IBD), which has led to new therapeutic strategies. We assessed the relevancy of IL-17 and IL-23 serum levels as potential biomarkers towar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78ba1f59f8d16024b29c2aa892084bbe

Zobrazit plný text záznamu

What is the Impact of the Proportion of Solid Necrotic Content on the Number of Necrosectomies during EUS-Guided Drainage using Lumen-Apposing Metallic Stents of Pancreatic Walled-off Necrosis ?

Autor: Sorana D. Bolboacă, Vasile Sandru, Ofelia Mostean, Mihai Rimbas, Adrian Bartos, Nadim Al Hajjar, Gabriel Constantinescu, Laura A. Lucaciu, Cristina Pojoga, Andrada Seicean, Madalina Ilie, Radu Seicean, Marcel Gheorghiu

Publikováno v: Journal of gastrointestinal and liver diseases : JGLD. 29(4)

Background and Aims: The fully-covered, lumen apposing metal stents are designed for one step placement, facilitating the direct endoscopic necrosectomy into the walled-off pancreatic necrosis. However, the prediction of the number of necrosectomy se

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bbdb0b2e08862325e2c75b042b4f8f8
https://pubmed.ncbi.nlm.nih.gov/34551032

Zobrazit plný text záznamu

THE ON-DEMAND NUMBER OF NECROSECTOMY SESSIONS DURING LUMEN APPOSING METAL STENTS DRAINAGE IN WALLED-OFF PANCREATIC NECROSIS CANNOT BE PREDICTED

Autor: N Al Hajjar, Ofelia Mosteanu, Adrian Bartos, Andrada Seicean, Marcel Gheorghiu, Laura A. Lucaciu, Cristina Pojoga, Radu Seicean

Publikováno v: ESGE Days.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2300ad0f3099a7e8f3f69d8afd43f9a0
https://doi.org/10.1055/s-0040-1704249

Zobrazit plný text záznamu

Depression and suicide ideation in chronic hepatitis C patients untreated and treated with interferon: prevalence, prevention, and treatment

Autor: Laura A, Lucaciu, Dan L, Dumitrascu

Publikováno v: Annals of Gastroenterology : Quarterly Publication of the Hellenic Society of Gastroenterology

Interferon-based therapies were until recently the standard of care in chronic hepatitis C (CHC), despite their side effects. We aimed to review the available data on the depression and suicide in CHC patients receiving or not antiviral therapy based

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a2c514ce7b3bba3e08e43330f2894fac
https://pubmed.ncbi.nlm.nih.gov/26424594

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání